1. Home
  2. Directory
  3. Missouri
  4. Mexico
  5. Psychiatry Neurology
  6. NPI Profile
  7. Prescriptions 1003970849

AHSAN SYED M.D.
Prescription History 1003970849
Psychiatry & Neurology - Psychiatry in Mexico, MO

NPI Status: Active since December 19, 2006

Contact Information

321 W PROMENADE ST
MEXICO, MO
ZIP 65265
Phone: (573) 582-1234
Fax: (573) 582-1212

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AHSAN SYED M.D., an active Psychiatry specialist practicing in Mexico, MO. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 56 documented patient claims. Among these therapy options, the most frequently utilized medication is Fluvoxamine Maleate, which accounts for 31 claims alone.

Medication Index

C
D
F
No matching medications currently found on file.

Clonidine Hcl

Generic Formulation: Clonidine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.2
Days Supply 340
MO State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills50.3
Peer Average Days Supply1,437
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.6% less volume than the regional standard for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $159.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.33

State Avg Cost Per Claim

$9.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.1
Days Supply 358
MO State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills70.0
Peer Average Days Supply1,751
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.4% less volume than the regional standard for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $679.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$52.30

State Avg Cost Per Claim

$44.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Fluvoxamine Maleate

Generic Formulation: Fluvoxamine MaleateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 31
30-Day Fills 31.4
Days Supply 893
MO State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills33.6
Peer Average Days Supply826
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,016.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.79

State Avg Cost Per Claim

$43.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.

Therapeutic Applications

Fluvoxamine is used to treat obsessive-compulsive disorder (OCD). It helps decrease thoughts that are unwanted or that don't go away (obsessions), and it helps to reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, checking) that interfere with daily living. Fluvoxamine is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like AHSAN SYED M.D. provides transparency into local medical care patterns within Mexico, MO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.